Who owns INMED PHARMACEUTICALS INC?
- Ticker: INM
- CUSIP Number: 457637700
Tip: Access positions for across all investors
Analyze quarterly positions in Inmed Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Inmed Pharmaceuticals stock
Who bought or sold INMED PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| ADAR1 Capital Management | 800k | $1.2M | 100% | Jun 2026 |
|
| Vivo Capital | 798k | $1.2M | 100% | Jun 2026 |
|
| Squadron Capital Management | 325k | $504k | 100% | Jun 2026 |
|
| Ikarian Capital | 245k | $380k | 100% | Jun 2026 |
|
| Ursa Fund Management | 126k | $195k | 100% | Jun 2026 |
|
| Suvretta Capital Management | 100k | $155k | 100% | Jun 2026 |
|
| Boothbay Fund Management | 74k | $115k | 100% | Jun 2026 |
|
| Sabby Management | 45k | $70k | -80% | Jun 2026 |
|
| Jane Street | 43k | $67k | 100% | Jun 2026 |
|
| VR Adviser | 33k | $51k | 100% | Jun 2026 |
|
| Citadel Advisors | 26k | $40k | -44% | Jun 2026 |
|
| Seven Grand Managers | 25k | $39k | 100% | Jun 2026 |
|
| Scientech Research | 16k | $24k | 100% | Jun 2026 |
|
| Crestwood Advisors | 15k | $23k | 100% | Jun 2026 |
|
| Two Sigma Securities | 11k | $17k | -42% | Jun 2026 |
|
| Stratos Wealth Partners | 11k | $17k | 100% | Jun 2026 |
|
| Private Wealth Management Group | 5.0k | $7.8k | 0% | Jun 2026 |
|
| SBI Securities | 300.00 | $465.000000 | 0% | Jun 2026 |
|
| Banque Cantonale Vaudoise | 6.00 | $1.0k | 0% | Jun 2026 |
|
| Federation des caisses Desjardins du Quebec | 2.00 | $4.000000 | 0% | Jun 2026 |
|
Who sold out of Inmed Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Virtu Financial | Mar 2026 | 20k | $13k |
| UBS Group | Mar 2026 | 8.1k | $5.2k |